Inspire Medical Systems, Inc. increased revenue guidance for the fiscal year 2023. For the period, the company expects revenue guidance to between $600 million to $610 million, which would represent growth of 47% to 50% over full year 2022 revenue of $407.9 million. This compares to the prior revenue guidance of $580 million to $590 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155.3 USD | +0.05% | -2.70% | -23.66% |
May. 15 | Transcript : Inspire Medical Systems, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM | |
May. 08 | Top Premarket Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.66% | 4.61B | |
+10.11% | 126B | |
-5.80% | 11.33B | |
+6.07% | 9.27B | |
+37.46% | 5.5B | |
+8.53% | 3.45B | |
-8.69% | 2.81B | |
-6.38% | 2.08B | |
-10.91% | 2.09B | |
-23.21% | 1.78B |
- Stock Market
- Equities
- INSP Stock
- News Inspire Medical Systems, Inc.
- Inspire Medical Systems, Inc. Increases Revenue Guidance for the Fiscal Year 2023